ALAB.NASDAQAstera Labs, INC

Form 4: Astera Labs Executive Sanjay Gajendra Sells Shares Under 10b5-1 Plan

Sentiment:

SEC Form 4


Sanjay Gajendra, President and COO of Astera Labs, sold a total of 110,000 shares of common stock on October 11, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

  • On October 11, 2024, Sanjay Gajendra, President and COO of Astera Labs, executed sales of Astera Labs [ALAB] common stock.
  • The sales were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on May 31, 2024.
  • A total of 110,000 shares were sold in three separate transactions.
  • 70,000 shares were sold at a price of $69.4813.
  • 20,000 shares were sold at a price of $69.4357.
  • 20,000 shares were sold at a price of $69.4389.
  • Following the reported transactions, Gajendra directly owns 2,704,335 shares.
  • Gajendra also indirectly owns 6,925,545 shares through Trust 1, 835,000 shares through Trust 2, and 835,000 shares through Trust 3.
  • Gajendra disclaims beneficial ownership of the shares held by the trusts, except to the extent of any pecuniary interest.

Sentiment

Score: 5

Explanation: The document itself is neutral, reporting a routine stock sale under a pre-existing plan. The impact on sentiment is likely to be minimal as these types of transactions are common.

Risks

  • Executive stock sales can sometimes be perceived negatively by the market, although sales under a 10b5-1 plan are typically viewed as less concerning since they are pre-planned.

Future Outlook

The document does not contain any specific forward-looking statements regarding the company's future performance.

Industry Context

Executive stock sales are a common occurrence in publicly traded companies. Monitoring these transactions can provide insights into management's perspective on the company's valuation and future prospects. Sales under 10b5-1 plans are less likely to be driven by short-term market views.

Stakeholder Impact

  • The stock sale could have a minor negative impact on shareholder sentiment, although the existence of a 10b5-1 plan mitigates this concern.

Key Dates

DateDescription
2024-05-31Date the Rule 10b5-1 trading plan was adopted.
2024-10-11Date of the stock sale transactions.
2024-10-15Date of the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.